<code id='2120B1C433'></code><style id='2120B1C433'></style>
    • <acronym id='2120B1C433'></acronym>
      <center id='2120B1C433'><center id='2120B1C433'><tfoot id='2120B1C433'></tfoot></center><abbr id='2120B1C433'><dir id='2120B1C433'><tfoot id='2120B1C433'></tfoot><noframes id='2120B1C433'>

    • <optgroup id='2120B1C433'><strike id='2120B1C433'><sup id='2120B1C433'></sup></strike><code id='2120B1C433'></code></optgroup>
        1. <b id='2120B1C433'><label id='2120B1C433'><select id='2120B1C433'><dt id='2120B1C433'><span id='2120B1C433'></span></dt></select></label></b><u id='2120B1C433'></u>
          <i id='2120B1C433'><strike id='2120B1C433'><tt id='2120B1C433'><pre id='2120B1C433'></pre></tt></strike></i>

          focus

          focus

          author:fashion    Page View:1
          Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

          In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

          The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks. 

          advertisement

          “Oh, crap,” Secrist said to herself.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          It was time to plan for my old age. If only I could stop crying
          It was time to plan for my old age. If only I could stop crying

          MikeReddyforSTATAtwo-dayexcursiontoNewHampshire,atthepeakoffallfoliageseason,shouldbeatreat.Sohowcom

          read more
          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more

          Disclosing genetic information: not as worrisome as once feared

          AdobeWhentheHumanGenomeProjectbeganin1990,bioethicistsfearedthatgivingpeopletheresultsofgenetictests